↓ Skip to main content

Cochrane Database of Systematic Reviews

Primaquine for preventing relapse in people withPlasmodium vivaxmalaria treated with chloroquine

Overview of attention for article published in Cochrane database of systematic reviews, October 2013
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (77th percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

policy
1 policy source
twitter
5 tweeters

Citations

dimensions_citation
64 Dimensions

Readers on

mendeley
269 Mendeley
Title
Primaquine for preventing relapse in people withPlasmodium vivaxmalaria treated with chloroquine
Published in
Cochrane database of systematic reviews, October 2013
DOI 10.1002/14651858.cd004389.pub3
Pubmed ID
Authors

Gawrie NL Galappaththy, Prathap Tharyan, Richard Kirubakaran

Abstract

Plasmodium vivax infections are an important contributor to the malaria burden worldwide. The World Health Organization recommends a 14-day course of primaquine (0.25 mg/kg/day, giving an adult dose of 15 mg/day) to eradicate the liver stage of the parasite and prevent relapse of the disease. Many people find a 14-day primaquine regimen difficult to complete, and there is a potential risk of haemolytic anaemia in people with glucose-6-phosphate-dehydrogenase enzyme (G6PD) deficiency. This review evaluates primaquine in P. vivax, particularly alternatives to the standard 14-day course.

Twitter Demographics

The data shown below were collected from the profiles of 5 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 269 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Germany 1 <1%
Italy 1 <1%
Brazil 1 <1%
United Kingdom 1 <1%
Japan 1 <1%
Unknown 264 98%

Demographic breakdown

Readers by professional status Count As %
Student > Master 46 17%
Researcher 32 12%
Student > Ph. D. Student 29 11%
Student > Bachelor 29 11%
Student > Postgraduate 16 6%
Other 51 19%
Unknown 66 25%
Readers by discipline Count As %
Medicine and Dentistry 87 32%
Nursing and Health Professions 26 10%
Agricultural and Biological Sciences 18 7%
Social Sciences 16 6%
Biochemistry, Genetics and Molecular Biology 12 4%
Other 35 13%
Unknown 75 28%

Attention Score in Context

This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 01 January 2022.
All research outputs
#4,355,000
of 21,446,675 outputs
Outputs from Cochrane database of systematic reviews
#6,802
of 12,054 outputs
Outputs of similar age
#43,299
of 207,916 outputs
Outputs of similar age from Cochrane database of systematic reviews
#50
of 98 outputs
Altmetric has tracked 21,446,675 research outputs across all sources so far. Compared to these this one has done well and is in the 76th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 12,054 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 29.2. This one is in the 42nd percentile – i.e., 42% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 207,916 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 77% of its contemporaries.
We're also able to compare this research output to 98 others from the same source and published within six weeks on either side of this one. This one is in the 48th percentile – i.e., 48% of its contemporaries scored the same or lower than it.